Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903. (Q43541840)
Jump to navigation
Jump to search
scientific article published in October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903. |
scientific article published in October 2008 |
Statements
1 reference
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903. (English)
1 reference
Juan Berenguer
1 reference
Juan González
1 reference
Pere Domingo
1 reference
Jesús Santos
1 reference
Pilar Miralles
1 reference
M Angels Ribas
1 reference
Víctor Asensi
1 reference
Juan Luis Gimeno
1 reference
José Alberto Terrón
1 reference
Juan Miguel Santamaría
1 reference
Enric Pedrol
1 reference
GESIDA 3903 Team
1 reference
1 October 2008
1 reference
1 reference
Identifiers
1 reference